Thrombosis in patient with lupus nephritis
Authors:
M. Kučera; E. Hirnerová
Authors‘ workplace:
Prednosta: Prof. MUDr. Andrej Dukát, CSc., FESH
; II. interná klinika LFUK a UN, Bratislava
Published in:
Prakt. Lék. 2011; 91(2): 106-109
Category:
Case Report
Overview
Kidney involvement in systemic lupus erythematosus (SLE) is common. The incidence of venous thrombosis in SLE ranges from 5–15 %. Venous thrombosis in lupus nephritis associated with nephritic syndrome or antiphospholipid antibody syndrome is reported in 30–35 %. Detection of antiphospholipid antibodies in the serum of patients with lupus nephritis is useful to identify patients at risk of thrombotic events.
Venous thromboembolism is also increased in lupus patients who have a history of smoking at the time of diagnosis. Lupus nephritis with nephrotic syndrome is not infrequently encountered at the point of diagnosis of SLE, but venous thrombosis as the first manifestation of SLE is rare.
Herein we present our clinical experience in a young men with SLE with venous thrombosis and onset arterial hypertension as the first manifestations of lupus nephritis.
Key words:
systemic lupus erythematosus, thrombosis, lupus nephritis, antiphospholipid antibodies.
Sources
1. Révayová, I. Klinické prejavy systémového lupus erytematozus. Via Practica, 2005, 2, s.86-88.
2. Austin, H.A., Boumpas, D.T., Vaughan, E.M. et al. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histological data. Kidney 1994, 45, p. 544-550.
3. Lukáč, J., Rovenský, O., Lukáčová, O. Systémový lupus erythematosus. Vnitř. Lék. 2006, 7, s. 702-710.
4. Tsuruta, Y., Uchida, K., Itabashi, M. et al. Antiphospholipid Antibodies and Renal Outcomes in Patients with lupus Nephritis. Inter Med, 2009, 48, p. 1875-1880.
5. Moroni, G., Ventura, D., Riva, P. et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am. J. Kidney Dis. 2004, 43, p. 28-36.
6. Nochy, D., Daugas, E., Droz, D. et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J. Am. Soc. Nephrol. 1999, 10, p.507-518.
7. Daugas, E., Nochy, D., du Hurong, L.T. et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J. Am. Soc. Nephrol. 2002, 13, p. 45-52.
8. Bhaudari, S., Haruden, P., Brownjohn, A.M. et al. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM, 1998, 91, p. 401-409.
9. Moroni, G., Ventura, D., Riva, P. et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am. J. Kidney Dis. 2004, 43, p. 28-36.
10. Zheng, M., Chen, Y., Ao, W. et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microtrombosis: a prospective study of 124 cases. Arthritis Research & Therapy 2009, 11, R 93.
11. Levine, J.S., Branch, D.W., Rauch, J. et al. The antiphospholipid syndrome. N. Engl. J. Med. 2002, 346, p. 752-763.
12. DeGroot, PG, Derksen, R.W. Antiphospholipid antibodies: update on detection, patophysiology, and treatment. Curr. Opin. Hematol. 2004, 11, p. 165-169.
13. Wahl, D.G, Guillemin, F, Maistre, E. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus – A meta-analysis. Lupus 1997, 6, p. 467-473.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2011 Issue 2
Most read in this issue
- Antiaggregation treatment – review of drugs, importance for clinical practice, and possibilities of determination of resistance to treatment
- Autoimmune haemolytic anaemias
-
Basics of social cognitive and affective neuroscience.
II. Empathy - Pulmonary embolism as a paraneoplastic symptom of choroid melanoma